Metabiomed Co Ltd
KOSDAQ:059210
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 935
6 520
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| KR |
M
|
Metabiomed Co Ltd
KOSDAQ:059210
|
122.8B KRW |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8.5T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
30.5B CHF |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
35.7B USD |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
121.4B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.4B USD |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
44.8B CNY |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.1B USD |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.5B CHF |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
771.3B JPY |
Loading...
|
Market Distribution
| Min | -163 055.6% |
| 30th Percentile | -2.2% |
| Median | 2.7% |
| 70th Percentile | 6.8% |
| Max | 22 874.8% |
Other Profitability Ratios
Metabiomed Co Ltd
Glance View
Meta Biomed Co., Ltd. engages in the manufacture and sale of surgical and other medical devices. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2008-04-15. The firm mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. The company also distributes dental-related products.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Metabiomed Co Ltd is 23.4%, which is above its 3-year median of 14.4%.
Over the last 3 years, Metabiomed Co Ltd’s Operating Margin has increased from 9% to 23.4%. During this period, it reached a low of 7.8% on Dec 31, 2022 and a high of 23.4% on Oct 30, 2025.